BCMA CAR-T therapy combined with pomalidomide is a safe and effective treatment for relapsed/refractory multiple myeloma

被引：0
|
作者：
Yuhan Yan [1 ]
Yixuan Tu [1 ]
Qian Cheng [1 ]
Jian Zhang [1 ]
Erhua Wang [1 ]
Zuqun Deng [1 ]
Yan Yu [1 ]
Liwen Wang [1 ]
Rui Liu [1 ]
Ling Chu [2 ]
Liqing Kang [3 ]
Jing Liu [1 ]
Xin Li [1 ]
机构：
[1] The Third Xiangya Hospital,Department of Hematology
[2] Central South University,Department of Pathology
[3] The Third Xiangya Hospital,undefined
[4] Central South University,undefined
[5] Shanghai Unicar-Therapy Bio-Medicine Technology Co,undefined
来源：
Journal of Translational Medicine | / 22卷 / 1期
关键词：
Relapsed/Refractory multiple myeloma (R/R MM); BCMA CAR T-cell therapy; Pomalidomide; Combination therapy;
D O I：
10.1186/s12967-024-05772-w
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Enhanced platelet function through CAR-T cell therapy in relapsed/refractory multiple myeloma
    Ma, Ruixue
    Zhang, Qi
    Liu, Yang
    Li, Hujun
    Chen, Huimin
    Zhang, Qianqian
    Qiao, Jianlin
    Qi, Kunming
    Shen, Guifang
    Sun, Cai
    Song, Xuguang
    Cao, Jiang
    Cheng, Hai
    Zhu, Feng
    Yan, Zhiling
    Sang, Wei
    Li, Depeng
    Sun, Haiying
    Zheng, Junnian
    Li, Zhenyu
    Xu, Kailin
    Chen, Wei
    CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 24 (01)
  • [42] Laryngeal edema as a symptom of local cytokine release syndrome after BCMA-targeting CAR-T therapy for relapsed and refractory multiple myeloma
    Nakanishi, Yoko
    Marumo, Yoshiaki
    Ri, Masaki
    Kinoshita, Shiori
    Suzuki, Tomotaka
    Narita, Tomoko
    Kusumoto, Shigeru
    Komatsu, Hirokazu
    Iida, Shinsuke
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 118 (05) : 647 - 651
  • [43] Impact of corticosteroids on efficacy of BCMA targeted CAR-T therapy in multiple myeloma
    Duvalyan, Eva
    Shah, Nina
    Lo, Mimi
    Martin III, Thomas
    Wolf, Jeffrey L.
    Chung, Alfred
    Arora, Shagun
    Huang, Chiung-Yu
    Wong, Sandy W.
    LEUKEMIA & LYMPHOMA, 2023,
  • [44] Laryngeal edema as a symptom of local cytokine release syndrome after BCMA-targeting CAR-T therapy for relapsed and refractory multiple myeloma
    Yoko Nakanishi
    Yoshiaki Marumo
    Masaki Ri
    Shiori Kinoshita
    Tomotaka Suzuki
    Tomoko Narita
    Shigeru Kusumoto
    Hirokazu Komatsu
    Shinsuke Iida
    International Journal of Hematology, 2023, 118 : 647 - 651
  • [45] Impact of corticosteroids on efficacy of BCMA targeted CAR-T therapy in multiple myeloma
    Duvalyan, Eva
    Shah, Nina
    Lo, Mimi
    Martin III, Thomas
    Wolf, Jeffrey L.
    Chung, Alfred
    Arora, Shagun
    Huang, Chiung-Yu
    Wong, Sandy W.
    LEUKEMIA & LYMPHOMA, 2023,
  • [46] Efficacy and Safety of CAR-T Therapy with Safety Switch Targeting Bcma for Patients with Relapsed/Refractory Multiple Myeloma in a Phase 1 Clinical Study
    Fu, Weijun, Sr.
    Du, Juan
    Jiang, Hua
    Cheng, Zhi
    Wei, Runhong
    Yu, Kang
    Jiang, Songfu
    He, Feng
    Fang, Hongliang
    Liu, Yarong
    Wang, Pin
    BLOOD, 2019, 134
  • [47] Phase I Study of BCMA CAR-T using instant manufacturing platform or traditional production process for relapsed/refractory multiple myeloma therapy
    Liu, Hui
    Wang, Ting
    Yang, Yazi
    Feng, Ru
    Li, Jiangtao
    Zhang, Chunli
    Bai, Jiefei
    Ding, Yanping
    Liu, Guanghua
    Wu, Fei
    Lu, Xinan
    He, Ting
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S5 - S5
  • [48] Clinical Outcome of Patients with Relapsed Refractory Multiple Myeloma Listed for BCMA Directed Commercial CAR T Therapy
    Al Hadidi, Samer
    Szabo, Aniko
    Esselmann, Jean
    Hammons, Lindsay
    Hussain, Munawwar
    Ogunsesan, Yetunde
    Thalambedu, Nishanth
    Khan, Fatima
    Sethi, Jaskirat
    Janardan, Abhishek
    Radhakrishnan, Sabarinath
    Thanendrarajan, Sharmilan
    Schinke, Carolina
    Dhakal, Binod
    Janz, Siegfried
    Chhabra, Saurabh
    D'Souza, Anita
    Zangari, Maurizio
    van Rhee, Frits
    Mohan, Meera
    BLOOD, 2022, 140 : 8038 - 8039
  • [49] Comprehensive Characterization of Prolonged Unexplained Cytopenias in Relapsed/Refractory Multiple Myeloma Patients Following BCMA-Directed CAR-T Cell Therapy
    Thibaud, Santiago
    Mia, Babu
    Van Oekelen, Oliver
    Mouhieddine, Tarek H.
    Schaniel, Christoph
    Ghodke-Puranik, Yogita
    Aleman, Adolfo
    Upadhyaya, Bhaskar
    Lancman, Guido
    Lagana, Alessandro
    Richard, Shambavi
    Rossi, Adriana
    Chari, Ajai
    Sanchez, Larysa
    Rodriguez, Cesar
    Cho, Hearn J.
    Richter, Joshua
    Hoffman, Ronald
    Jagannath, Sundar
    Parekh, Samir
    BLOOD, 2022, 140
  • [50] Impact of Corticosteroids on Efficacy of BCMA Targeted CAR-T Therapy in Multiple Myeloma
    Duvalyan, Eva
    Lo, Mimi
    Martin, Thomas
    Wolf, Jeffrey L.
    Chung, Alfred
    Arora, Shagun
    Shah, Nina
    Huang, Chiung-Yu
    Wong, Sandy W.
    BLOOD, 2021, 138
12345